It is currently Fri Jul 03, 2015 3:13 pm

News News of ThisIsMS

Site map of ThisIsMS » Forum : ThisIsMS

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.

information and website

hello,
Have been researching and gathering information about LDN and people's experiences and alternative methods for MS in exploration for my own MS. This site and people has been very helpful. Many may already be connected to this, but, I have also joined the LDN Yahoo website, which has been a great connection. I have posted some interesting informative links and recent news from that site, below:

http://tinyurl.com/grpm9

...
Read more : information and website | Views : 2208 | Replies : 0 | Forum : Low Dose Naltrexone


This Is Athens!

Hello to everyone from Athens, Greece!

Im kaizen aka Thanos, 29 years old, and i have MS. I'm married to a wonderful woman who makes the sun shine brighter for me (no she is not reading this...). I hate my underpaid job, which requires me to commute for a full hour in the morning and another one in the afternoon, but on the other hand, im glad i at least have a job...

On October ...
Read more : This Is Athens! | Views : 2348 | Replies : 10 | Forum : Introductions


Symadex

Xanthus Pharmaceuticals, Inc. presented preclinical results from the Company’s FLT3 autoimmune program that describe a novel mechanism of action for achieving prolonged disease attenuation in an animal model for multiple sclerosis (MS). The experiments showed that Symadex™, the lead compound from Xanthus’ FLT3 autoimmune program, directly targets macrophages and monocytes, key cells responsible for driving the autoimmune response. Stephen J. Karlik, Ph.D., Professor of Diagnostic Radiology at the University of Western Ontario, London, Ontario, described ...
Read more : Symadex | Views : 1365 | Replies : 0 | Forum : Drug Pipeline


Possible new role for blood in the brain

This seems like a bizarre idea and a completely different view on how the brain might work, but a new twist in thinking might be just what we need:



Public release date: 15-Oct-2007


Contact: Elizabeth Thomson
thomson@mit.edu
617-258-5402
Massachusetts Institute of Technology
MIT: blood may help us think
CAMBRIDGE, Mass.--MIT scientists propose that blood may help us think, in addition ...
Read more : Possible new role for blood in the brain | Views : 1734 | Replies : 1 | Forum : General Discussion


Histone deacetylase (HDAC) inhibitors stimulate T-reg Cells

Cancer drugs could fight autoimmune disease

* 16 October 2007
* NewScientist.com news service

Many anti-cancer drugs have the unfortunate side-effect of depressing the body's immune system. So it makes sense that one class of these drugs is being investigated as a way of tackling autoimmune diseases like multiple sclerosis and rheumatoid arthritis. These are triggered when the immune system's T-cells go into overdrive and attack the body's own cells.

Wayne Hancock and colleagues at ...
Read more : Histone deacetylase (HDAC) inhibitors stimulate T-reg Cells | Views : 1378 | Replies : 0 | Forum : Drug Pipeline




Biogen is up for sale

Here's some recent news on Biogen. Apparently, their board of directors is considering putting the company up for sale.

Biogen's management gets OK to consider sale

Biogen IDEC Issues Statement

NHE
Read more : Biogen is up for sale | Views : 1514 | Replies : 0 | Forum : General Discussion


New here

My name is Lauri and I was diagnosed with MS in 2004. I started on Avonex and loved it but unfortunately had to switch to Rebif. I have gone on disability in the last year.

Lauri xo
Read more : New here | Views : 1650 | Replies : 4 | Forum : Introductions


ECTRIMS report

A post-hoc analysis from a Phase III clinical trial of AVONEX(R) (interferon beta-1a) and post-randomization eight-year follow up shows that six-month sustained progression of disability at two years, using the Expanded Disability Status Scale (EDSS), is a significant predictor of long-term disability, as measured by EDSS milestones of 4.0, 5.0, 6.0 and 7.0 at eight years, in patients with relapsing-remitting multiple sclerosis (RRMS).

The analysis suggests that patients taking AVONEX for two years were less ...
Read more : ECTRIMS report | Views : 2295 | Replies : 2 | Forum : Avonex


Gene variants linked to MS

Three gene variants have been found to correlate with susceptibility to multiple sclerosis, according to findings of the International Multiple Sclerosis Genetics Consortium (IMSGC) presented here at the 132nd Annual Meeting of the American Neurological Association (ANA).

Variants of interleukin 2RA, interleukin 7RA and CD58 were found to correlate with multiple sclerosis in a whole genome analysis that included about 4,500 participants. "The same finding has been reported in two other papers as well," noted ...
Read more : Gene variants linked to MS | Views : 1827 | Replies : 7 | Forum : General Discussion


 

Login  •  Register


Statistics

Total posts 226247 • Total topics 23794 • Total members 15097


Contact us | Terms of Service